Cancer Diagnostics Market By Application (Breast Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancer, Prostate Cancer, Skin Cancer, Blood Cancer, Kidney Cancer, Liver Cancer, Pancreatic Cancer, Ovarian Cancer, Others), By End-use Industry (Hospitals & Clinics, Diagnostic Laboratories, Diagnostic Imaging Centers, Research Institutes, Others), By Geography - Global Opportunity Analysis & Industry Forecast, 2022-2027

Report Code: HCR 0195 Report Format: PDF + Excel

Cancer Diagnostics Market Overview

The Cancer Diagnostics Market size is estimated to reach $241.7 billion by 2027, growing at a CAGR of 6.3% during the forecast period 2022-2027. Cancer Diagnostics includes tests and processes to ratify the existence of ailment and recognize the precise tumor type, location, extent and phase. Magnetic resonance imaging (MRI) is a test that can be utilized to detect a tumor in the body and to assist in discovering whether a tumor is cancerous. Artificial Intelligence enabled MRI results in improved MRI scans. Circulating tumor cells (CTCs), symbolize a comparably effortlessly achievable sample of the cancer tissue signifying the actual state of cancer. Low-Dose CT Technology involves a low-dose CT scan which is the recommended screening test for lung cancer. The alfa-fetoprotein test (AFP) may indicate an increased level of AFP in 70% of patients with liver cancer. The expanding population of the elderly requiring magnetic resonance imaging is set to drive the Cancer Diagnostics Market. The augmenting collaborative and independent actions directed by governments and firms are set to propel the growth of the Cancer Diagnostics Industry during the forecast period 2022-2027. This represents the Cancer Diagnostics Industry Outlook.

Cancer Diagnostics Market Report Coverage

The report: Cancer Diagnostics Market Report - Forecast (2022-2027)” by IndustryARC, covers an in-depth analysis of the following segments in the Cancer Diagnostics Market.

By Application: Breast Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancer, Prostate Cancer, Skin Cancer, Blood Cancer, Kidney Cancer, Liver Cancer, Pancreatic Cancer, Ovarian Cancer, Others.
By End-use Industry: Hospitals And Clinics, Diagnostic Laboratories, Diagnostic Imaging Centers, Research Institutes, Others.
By Geography: North America (the U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and the Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America) and Rest Of The World (the Middle East and Africa).

Key Takeaways

  • Geographically, North America accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the increasing predominance of cancer requiring magnetic resonance imaging in the North American region.
  • Cancer Diagnostics Market growth is being driven by the rising penetration of technologically progressive laboratory systems enhancing oncological screening yielding precise outcomes and application of Artificial Intelligence enabled MRI. However, binding regulatory framework, dearth of universal health coverage and high-priced diagnostic procedures are some of the major factors hampering the growth of the Cancer Diagnostics Market.
  • Cancer Diagnostics Market Detailed Analysis of the Strength, Weaknesses and Opportunities of the prominent players operating in the market will be provided in the Cancer Diagnostics Market report. 

Cancer Diagnostics Market: Market Share (%) by Region, 2021

For more details on this report - Request for Sample

Cancer Diagnostics Market Segment Analysis - By Application

The Cancer Diagnostics Market based on the application can be further segmented into Breast Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancer, Prostate Cancer, Skin Cancer, Blood Cancer, Kidney Cancer, Liver Cancer, Pancreatic Cancer, Ovarian Cancer and Others. The Breast Cancer Segment held the largest Cancer Diagnostics market share in 2021. This growth is owing to the increasing predominance of breast cancer. Breast cancer is cancer that establishes in the breast cells and advances in phases. The rising application of mammograms is further propelling the growth of the Breast Cancer segment.

Furthermore, the Lung Cancer segment is estimated to grow with the fastest CAGR of 8.1% during the forecast period 2022-2027 owing to the proliferating count of smokers worldwide and the rising risk of lung cancer in people who have never smoked.

Cancer Diagnostics Market Segment Analysis - By End-use Industry

The Cancer Diagnostics Market based on end-use industry can be further segmented into Hospitals And Clinics, Diagnostic Laboratories, Diagnostic Imaging Centers, Research Institutes and Others. The Hospitals And Clinics Segment held the largest Cancer Diagnostics market share in 2021. This growth is owing to the existence of top cancer hospitals like MD Anderson Cancer Center in the U.S. The availability of the best cancer treatments at an economical price in the U.S., UK and cancer hospitals in India is further propelling the growth of this segment. Furthermore, the Diagnostic Imaging Centers segment is estimated to grow with the fastest CAGR of 8.3% during the forecast period 2022-2027 owing to the crucial role played by diagnostic imaging in initial cancer diagnosis, treatment planning and corrective therapies by way of interventional therapies and cancer monitoring.

Cancer Diagnostics Market Segment Analysis - By Geography

North America held the largest Cancer Diagnostics market share with 35% of the overall market in 2021. The growth of this region is owing to the directed research endeavors in oncology in the North American region. The heightening grants from government healthcare agencies are further propelling the growth of the Cancer Diagnostics Industry, thereby contributing to the Cancer Diagnostics Industry Outlook, in the North American region. Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors like the supportive regulatory framework in the Asia-Pacific region. The burgeoning patient pool in India, China and Japan is further fuelling the progress of the Cancer Diagnostics Market in the Asia-Pacific region.

Cancer Diagnostics Market Drivers

Increasing Applications of Magnetic Resonance Imaging and Artificial Intelligence enabled MRI are Projected to Drive the Growth of Cancer Diagnostics Market:

There have been far-reaching advancements in the application of magnetic resonance imaging (MRI) to the detection and diagnosis of breast cancer. Contrast-enhanced magnetic resonance imaging (MRI) has been demonstrated to have value in the diagnostic work-up of women who submit with mammograms or clinical abnormalities. Magnetic resonance imaging can detect mammogram occult multifocal cancer in patients declared with unifocal disease. Artificial Intelligence-enabled MRI involves researchers utilizing machine learning to enhance images from MRI scanners. The Artificial Intelligence (AI) machines reading radiology investigations correctly, attain about 95 percent accuracy. The increasing applications of Magnetic Resonance Imaging and Artificial Intelligence enabled MRI is therefore fuelling the growth of the Cancer Diagnostics Market during the forecast period 2022-2027.

Rising Applications of Low-Dose CT Technology and Alfa-fetoprotein test are Expected to Boost the Growth of the Cancer Diagnostics Industry:

A Low-Dose CT Technology (LDCT) scan offers quality images that assist in detecting tiny abnormalities utilizing 90 percent less ionizing radiation than a standard CT scan of the chest, as per the RSNA and the ACR. Alfa-fetoprotein test (AFP) is utilized as a tumor marker to assist in detecting and diagnosing cancers of the liver testicles and ovaries. These kinds of rising applications of Low-Dose CT Technology and Alfa-fetoprotein test are therefore driving the growth of the Cancer Diagnostics Industry, thereby contributing to the Cancer Diagnostics Industry Outlook during the forecast period 2022-2027.

Cancer Diagnostics Market Challenge

Challenges in Cancer Diagnostics are Hampering the Growth of the Cancer Diagnostics Market:

In spite of the considerable progress in cancer diagnostics, there exist challenges in the field. These involve precision of diagnosis, early detection and the level of invasiveness. In certain cases, the diagnostic procedure is greatly invasive, needing patients to endure risky surgical procedures to acquire a diagnosis. False negatives happen repeatedly with mammograms owing to disadvantages in the sensitivity of diagnostic tools. It is approximated that 1 in 5 cases of breast cancers are undiagnosed. These issues are thus hampering the growth of the Cancer Diagnostics Market.

Cancer Diagnostics Industry Outlook

Novel product launches, mergers and acquisitions, partnerships, agreements, collaborations and geographical expansions are key strategies adopted by players in the Cancer Diagnostics Market. The top 10 companies in the Cancer Diagnostics market are:

  1. GE Healthcare
  2. Abbott
  3. Hoffmann-La Roche Ltd.
  4. Siemens Healthineers
  5. Becton Dickinson & Company
  6. Illumina, Inc.
  7. Koninklijke Philips N.V.
  8. Hologic, Inc.
  9. Thermo Fisher Scientific Inc.
  10. Qiagen

Recent Developments

  • In July 2022, GE Healthcare declared the introduction of its 5G Innovation Lab in India. This is the earliest for GE Healthcare across the world. The 5G Innovation Lab is planned to place GE Healthcare at the front line of these pioneering breakthroughs in patient care.
  • In June 2022, Karkinos Healthcare introduced the ‘Advanced Centre For Cancer Diagnostics and Research’ in Kochi. It will act as a central laboratory for the Karkinos’ global oncology network. It will evaluate specimens at the molecular and genomic levels to support personalized targeted therapy.
  • In February 2020, GE Healthcare introduced a novel Medical Device Cybersecurity Offering. It is to assist health systems in better safeguarding against hazards. 

Relevant Reports:

Cancer Immunotherapy Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth and Forecast Analysis
Report Code: HCR 0197

Companion Diagnostics Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth and Forecast Analysis
Report Code: HCR 0055

Anti-Cancer Drugs Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth and Forecast Analysis
Report Code: HCR 0965 

For more Lifesciences and Healthcare related reports, please click here

1. Cancer Diagnostics Market Overview
    1.1 Definitions and Scope
2. Cancer Diagnostics Market - Executive Summary
3. Cancer Diagnostics Market – Market Landscape
    3.1 Company Benchmarking - Key Companies
    3.2 Key Company Financial Analysis
    3.3 Market Share Analysis
    3.4 Patent Analysis
    3.5 Pricing Analysis (Comparison of General Price Offerings in the Market)
4. Cancer Diagnostics Market – Startup Company Scenario (Premium)
    4.1 Investment
    4.2 Revenue
    4.3 Venture Capital and Funding Scenario
5. Cancer Diagnostics Market – Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Scenario
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Cancer Diagnostics Market - Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porter's five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Cancer Diagnostics Market – Strategic Analysis
    7.1 Value Chain Analysis 
    7.2 Opportunities Analysis
    7.3 Market Life Cycle Analysis
8. Cancer Diagnostics Market – by Application (Market Size – $Million/$Billion) 
    8.1 Breast Cancer
    8.2 Colorectal Cancer
    8.3 Cervical Cancer
    8.4 Lung Cancer
    8.5 Prostate Cancer
    8.6 Skin Cancer
    8.7 Blood Cancer
    8.8 Kidney Cancer
    8.9 Liver Cancer
    8.10 Pancreatic Cancer
    8.11 Ovarian Cancer
    8.12 Others
9. Cancer Diagnostics Market – by End-use Industry (Market Size – $Million/$Billion) 
    9.1 Hospitals And Clinics
    9.2 Diagnostic Laboratories
    9.3 Diagnostic Imaging Centers
    9.4 Research Institutes
    9.5 Others
10. Cancer Diagnostics Market - by Geography (Market Size - $Million/Billion)
    10.1 North America
        10.1.1 the U.S.
        10.1.2 Canada
        10.1.3 Mexico
    10.2 Europe
        10.2.1 Germany
        10.2.2 France
        10.2.3 the UK
        10.2.4 Italy
        10.2.5 Spain
        10.2.6 Russia
        10.2.7 Rest of Europe
    10.3 Asia-Pacific
        10.3.1 China
        10.3.2 Japan
        10.3.3 South Korea
        10.3.4 India
        10.3.5 Australia & New Zealand
        10.3.6 Rest of Asia-Pacific
    10.4 South America
        10.4.1 Brazil
        10.4.2 Argentina
        10.4.3 Chile
        10.4.4 Colombia
        10.4.5 Rest of South America
    10.5 Rest Of The World
        10.5.1 the Middle East
        10.5.2 Africa
11. Cancer Diagnostics Market - Market Entropy
    11.1 New product launches
    11.2 M&A's, collaborations, JVs and partnerships
12. Cancer Diagnostics Market – Industry Competition Landscape (Premium)
    12.1 Market Share Analysis
        12.1.1 Market Share by Region – Key Companies
        12.1.2 Market Share by Countries – Key Companies
    12.2 Competition Matrix
    12.3 Best Practices for Companies
13. Cancer Diagnostics Market – Key Company List by Country Premium (Premium)
14. Cancer Diagnostics Market - Company Analysis
    14.1 Company 1
    14.2 Company 2
    14.3 Company 3
    14.4 Company 4
    14.5 Company 5
    14.6 Company 6
    14.7 Company 7
    14.8 Company 8
    14.9 Company 9
    14.10 Company 10
* "Financials would be provided to private companies on best-efforts basis."
Connect with our experts to get customized reports that best suit your requirements. Our reports include global-level data, niche markets and competitive landscape.
List of Tables:

Table 1: Cancer Diagnostics Market Overview 2021-2026
Table 2: Cancer Diagnostics Market Leader Analysis 2018-2019 (US$)
Table 3: Cancer Diagnostics Market Product Analysis 2018-2019 (US$)
Table 4: Cancer Diagnostics Market End User Analysis 2018-2019 (US$)
Table 5: Cancer Diagnostics Market Patent Analysis 2013-2018* (US$)
Table 6: Cancer Diagnostics Market Financial Analysis 2018-2019 (US$)
Table 7: Cancer Diagnostics Market Driver Analysis 2018-2019 (US$)
Table 8: Cancer Diagnostics Market Challenges Analysis 2018-2019 (US$)
Table 9: Cancer Diagnostics Market Constraint Analysis 2018-2019 (US$)
Table 10: Cancer Diagnostics Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Cancer Diagnostics Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Cancer Diagnostics Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Cancer Diagnostics Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Cancer Diagnostics Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Cancer Diagnostics Market Value Chain Analysis 2018-2019 (US$)
Table 16: Cancer Diagnostics Market Pricing Analysis 2021-2026 (US$)
Table 17: Cancer Diagnostics Market Opportunities Analysis 2021-2026 (US$)
Table 18: Cancer Diagnostics Market Product Life Cycle Analysis 2021-2026 (US$)
Table 19: Cancer Diagnostics Market Supplier Analysis 2018-2019 (US$)
Table 20: Cancer Diagnostics Market Distributor Analysis 2018-2019 (US$)
Table 21: Cancer Diagnostics Market Trend Analysis 2018-2019 (US$)
Table 22: Cancer Diagnostics Market Size 2018 (US$)
Table 23: Cancer Diagnostics Market Forecast Analysis 2021-2026 (US$)
Table 24: Cancer Diagnostics Market Sales Forecast Analysis 2021-2026 (Units)
Table 25: Cancer Diagnostics Market, Revenue & Volume, By Product Type, 2021-2026 ($)
Table 26: Cancer Diagnostics Market By Product Type, Revenue & Volume, By Next-generation Sequencing, 2021-2026 ($)
Table 27: Cancer Diagnostics Market By Product Type, Revenue & Volume, By Microarrays, 2021-2026 ($)
Table 28: Cancer Diagnostics Market By Product Type, Revenue & Volume, By PCR, 2021-2026 ($)
Table 29: Cancer Diagnostics Market By Product Type, Revenue & Volume, By Flow Cytometry, 2021-2026 ($)
Table 30: Cancer Diagnostics Market By Product Type, Revenue & Volume, By In situ Hybridization, 2021-2026 ($)
Table 31: Cancer Diagnostics Market, Revenue & Volume, By Cancer Treated, 2021-2026 ($)
Table 32: Cancer Diagnostics Market By Cancer Treated, Revenue & Volume, By Breast Cancer, 2021-2026 ($)
Table 33: Cancer Diagnostics Market By Cancer Treated, Revenue & Volume, By Prostate Cancer, 2021-2026 ($)
Table 34: Cancer Diagnostics Market By Cancer Treated, Revenue & Volume, By Ovarian Cancer, 2021-2026 ($)
Table 35: Cancer Diagnostics Market By Cancer Treated, Revenue & Volume, By Thyroid Cancer, 2021-2026 ($)
Table 36: Cancer Diagnostics Market By Cancer Treated, Revenue & Volume, By Kidney Cancer, 2021-2026 ($)
Table 37: North America Cancer Diagnostics Market, Revenue & Volume, By Product Type, 2021-2026 ($)
Table 38: North America Cancer Diagnostics Market, Revenue & Volume, By Cancer Treated, 2021-2026 ($)
Table 39: South america Cancer Diagnostics Market, Revenue & Volume, By Product Type, 2021-2026 ($)
Table 40: South america Cancer Diagnostics Market, Revenue & Volume, By Cancer Treated, 2021-2026 ($)
Table 41: Europe Cancer Diagnostics Market, Revenue & Volume, By Product Type, 2021-2026 ($)
Table 42: Europe Cancer Diagnostics Market, Revenue & Volume, By Cancer Treated, 2021-2026 ($)
Table 43: APAC Cancer Diagnostics Market, Revenue & Volume, By Product Type, 2021-2026 ($)
Table 44: APAC Cancer Diagnostics Market, Revenue & Volume, By Cancer Treated, 2021-2026 ($)
Table 45: Middle East & Africa Cancer Diagnostics Market, Revenue & Volume, By Product Type, 2021-2026 ($)
Table 46: Middle East & Africa Cancer Diagnostics Market, Revenue & Volume, By Cancer Treated, 2021-2026 ($)
Table 47: Russia Cancer Diagnostics Market, Revenue & Volume, By Product Type, 2021-2026 ($)
Table 48: Russia Cancer Diagnostics Market, Revenue & Volume, By Cancer Treated, 2021-2026 ($)
Table 49: Israel Cancer Diagnostics Market, Revenue & Volume, By Product Type, 2021-2026 ($)
Table 50: Israel Cancer Diagnostics Market, Revenue & Volume, By Cancer Treated, 2021-2026 ($)
Table 51: Top Companies 2018 (US$)Cancer Diagnostics Market, Revenue & Volume
Table 52: Product Launch 2018-2019Cancer Diagnostics Market, Revenue & Volume
Table 53: Mergers & Acquistions 2018-2019Cancer Diagnostics Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Cancer Diagnostics Market 2021-2026
Figure 2: Market Share Analysis for Cancer Diagnostics Market 2018 (US$)
Figure 3: Product Comparison in Cancer Diagnostics Market 2018-2019 (US$)
Figure 4: End User Profile for Cancer Diagnostics Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Cancer Diagnostics Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Cancer Diagnostics Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Cancer Diagnostics Market 2018-2019
Figure 8: Ecosystem Analysis in Cancer Diagnostics Market 2018
Figure 9: Average Selling Price in Cancer Diagnostics Market 2021-2026
Figure 10: Top Opportunites in Cancer Diagnostics Market 2018-2019
Figure 11: Market Life Cycle Analysis in Cancer Diagnostics Market
Figure 12: GlobalBy Product TypeCancer Diagnostics Market Revenue, 2021-2026 ($)
Figure 13: GlobalBy Cancer TreatedCancer Diagnostics Market Revenue, 2021-2026 ($)
Figure 14: Global Cancer Diagnostics Market - By Geography
Figure 15: Global Cancer Diagnostics Market Value & Volume, By Geography, 2021-2026 ($) 
Figure 16: Global Cancer Diagnostics Market CAGR, By Geography, 2021-2026 (%)
Figure 17: North America Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 18: US Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 19: US GDP and Population, 2018-2019 ($)
Figure 20: US GDP – Composition of 2018, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2018-2019 ($)
Figure 22: Canada Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 23: Canada GDP and Population, 2018-2019 ($)
Figure 24: Canada GDP – Composition of 2018, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 26: Mexico Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 27: Mexico GDP and Population, 2018-2019 ($)
Figure 28: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 30: South America Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 31: Brazil Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 32: Brazil GDP and Population, 2018-2019 ($)
Figure 33: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 35: Venezuela Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 36: Venezuela GDP and Population, 2018-2019 ($)
Figure 37: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 39: Argentina Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 40: Argentina GDP and Population, 2018-2019 ($)
Figure 41: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 43: Ecuador Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 44: Ecuador GDP and Population, 2018-2019 ($)
Figure 45: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 47: Peru Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 48: Peru GDP and Population, 2018-2019 ($)
Figure 49: Peru GDP – Composition of 2018, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 51: Colombia Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 52: Colombia GDP and Population, 2018-2019 ($)
Figure 53: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 55: Costa Rica Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 56: Costa Rica GDP and Population, 2018-2019 ($)
Figure 57: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 59: Europe Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 60: U.K Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 61: U.K GDP and Population, 2018-2019 ($)
Figure 62: U.K GDP – Composition of 2018, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 64: Germany Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 65: Germany GDP and Population, 2018-2019 ($)
Figure 66: Germany GDP – Composition of 2018, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 68: Italy Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 69: Italy GDP and Population, 2018-2019 ($)
Figure 70: Italy GDP – Composition of 2018, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 72: France Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 73: France GDP and Population, 2018-2019 ($)
Figure 74: France GDP – Composition of 2018, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2018-2019 ($)
Figure 76: Netherlands Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 77: Netherlands GDP and Population, 2018-2019 ($)
Figure 78: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 80: Belgium Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 81: Belgium GDP and Population, 2018-2019 ($)
Figure 82: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 84: Spain Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 85: Spain GDP and Population, 2018-2019 ($)
Figure 86: Spain GDP – Composition of 2018, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 88: Denmark Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 89: Denmark GDP and Population, 2018-2019 ($)
Figure 90: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 92: APAC Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 93: China Cancer Diagnostics Market Value & Volume, 2021-2026
Figure 94: China GDP and Population, 2018-2019 ($)
Figure 95: China GDP – Composition of 2018, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2018-2019 ($)Cancer Diagnostics Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 97: Australia Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 98: Australia GDP and Population, 2018-2019 ($)
Figure 99: Australia GDP – Composition of 2018, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 101: South Korea Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 102: South Korea GDP and Population, 2018-2019 ($)
Figure 103: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 105: India Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 106: India GDP and Population, 2018-2019 ($)
Figure 107: India GDP – Composition of 2018, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2018-2019 ($)
Figure 109: Taiwan Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 110: Taiwan GDP and Population, 2018-2019 ($)
Figure 111: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 113: Malaysia Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 114: Malaysia GDP and Population, 2018-2019 ($)
Figure 115: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 117: Hong Kong Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 118: Hong Kong GDP and Population, 2018-2019 ($)
Figure 119: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 121: Middle East & Africa Cancer Diagnostics Market Middle East & Africa 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 122: Russia Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 123: Russia GDP and Population, 2018-2019 ($)
Figure 124: Russia GDP – Composition of 2018, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 126: Israel Cancer Diagnostics Market Value & Volume, 2021-2026 ($)
Figure 127: Israel GDP and Population, 2018-2019 ($)
Figure 128: Israel GDP – Composition of 2018, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 130: Entropy Share, By Strategies, 2018-2019* (%)Cancer Diagnostics Market
Figure 131: Developments, 2018-2019*Cancer Diagnostics Market
Figure 132: Company 1 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 133: Company 1 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 134: Company 1 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 135: Company 2 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 2 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 2 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 3 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 3 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 3 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 4 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 4 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 4 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 5 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 5 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 5 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 6 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 6 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 6 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 7 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 7 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 7 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 8 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 8 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 8 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 9 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 9 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 9 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 10 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 10 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 10 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 11 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 11 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 11 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 12 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 12 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 12 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 13 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 13 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 13 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 14 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 14 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 14 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 15 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 15 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 15 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)